{
    "xml": "<topic id=\"PHP3037\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/midazolam\" basename=\"midazolam\" title=\"MIDAZOLAM\">\n<title>MIDAZOLAM</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_421\" namespace=\"/interactions/list-of-drug-interactions/anxiolytics-and-hypnotics/benzodiazepines/midazolam\">Midazolam</xref>\n</p>\n<data name=\"vtmid\">26800000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_916643688\" title=\"Hypnotics and sedatives (benzodiazepine)\">Hypnotics and sedatives (benzodiazepine)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34584\" title=\"BENZODIAZEPINES\" namespace=\"/drug-classes/benzodiazepines\">BENZODIAZEPINES</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">   </data>\n</data>\r\n</body>\n<topic id=\"PHP40512\" outputclass=\"indicationsAndDose\" rev=\"1.94\" parent=\"/drugs/midazolam\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Status epilepticus</p>\n<p outputclass=\"therapeuticIndication\">Febrile convulsions</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By buccal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;2 months</p>\n<p>300&#8239;micrograms/kg (max. per dose 2.5&#8239;mg), then 300&#8239;micrograms/kg after 10&#8239;minutes (max. per dose 2.5&#8239;mg) if required.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 3&#8211;11 months</p>\n<p>2.5&#8239;mg, then 2.5&#8239;mg after 10&#8239;minutes if required.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 1&#8211;4 years</p>\n<p>5&#8239;mg, then 5&#8239;mg after 10&#8239;minutes if required.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 5&#8211;9 years</p>\n<p>7.5&#8239;mg, then 7.5&#8239;mg after 10&#8239;minutes if required.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>10&#8239;mg, then 10&#8239;mg after 10&#8239;minutes if required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Conscious sedation for procedures</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 2&#8211;2.5&#8239;mg, to be administered 5&#8211;10 minutes before procedure at a rate of approximately 2&#8239;mg/minute, increased in steps of 1&#8239;mg if required, usual total dose is 3.5&#8211;5&#8239;mg; maximum 7.5&#8239;mg per course.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 0.5&#8211;1&#8239;mg, to be administered 5&#8211;10 minutes before procedure at a rate of approximately 2&#8239;mg/minute, increased in steps of 0.5&#8211;1&#8239;mg if required; maximum 3.5&#8239;mg per course.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Sedative in combined anaesthesia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>30&#8211;100&#8239;micrograms/kg, repeated if necessary, alternatively (by continuous intravenous infusion) 30&#8211;100&#8239;micrograms/kg/hour.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Lower doses needed.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Premedication</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By deep intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>70&#8211;100&#8239;micrograms/kg, to be administered 20&#8211;60 minutes before induction, for debilitated patients, use elderly dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>25&#8211;50&#8239;micrograms/kg, to be administered 20&#8211;60 minutes before induction.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8211;2&#8239;mg, repeated if necessary, to be administered 5&#8211;30 minutes before procedure, for debilitated patients, use elderly dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>0.5&#8239;mg, repeated if necessary, initial dose to be administered 5&#8211;30 minutes before procedure, repeat dose slowly as required.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Induction of anaesthesia (but rarely used)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>150&#8211;200&#8239;micrograms/kg daily in divided doses (max. per dose 5&#8239;mg), dose to be given at intervals of 2 minutes, maximum total dose 600&#8239;micrograms/kg, for debilitated patients, use elderly dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>50&#8211;150&#8239;micrograms/kg daily in divided doses (max. per dose 5&#8239;mg), dose to be given at intervals of 2 minutes, maximum total dose 600&#8239;micrograms/kg.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Sedation of patient receiving intensive care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 30&#8211;300&#8239;micrograms/kg, dose to be given in steps of 1&#8211;2.5&#8239;mg every 2 minutes, then (by slow intravenous injection or by continuous intravenous infusion) 30&#8211;200&#8239;micrograms/kg/hour, reduce dose (or reduce or omit initial dose) in hypovolaemia, vasoconstriction, or hypothermia, lower doses may be adequate if opioid analgesic also used.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Confusion and restlessness in palliative care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By subcutaneous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8211;20&#8239;mg/24 hours, adjusted according to response; usual dose 20&#8211;60&#8239;mg/24 hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Convulsions in palliative care</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By continuous subcutaneous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 20&#8211;40&#8239;mg/24 hours.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40451\" outputclass=\"unlicensedUse\" rev=\"1.29\" parent=\"/drugs/midazolam\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Oromucosal solution not licensed for use in children under 3 months.</p>\n<p>Oromucosal solution not licensed for use in adults over 18 years.</p>\n<p>Unlicensed oromucosal formulations are also available and may have different doses&#8212;refer to product literature.</p>\n<p>Injection not licensed for use in status epilepticus or febrile convulsions.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Not licensed for use in children under 6 months for premedication and conscious sedation.</p>\n<p>Not licensed for use by mouth.</p>\n<p>Not licensed for use by buccal administration for conscious sedation.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40564\" outputclass=\"importantSafetyInformation\" rev=\"1.28\" parent=\"/drugs/midazolam\">\n<title>Important safety information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"title\">Anaesthesia</p>\n<p>Benzodiazepines should only be administered for anaesthesia by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"title\">Prescribing of midazolam in pallative care</p>\n<p>The use of high-strength midazolam (5&#8239;mg/mL in 2&#8239;mL and 10&#8239;mL ampoules, or 2&#8239;mg/mL in 5&#8239;mL ampoules) should be considered in palliative care and other situations where a higher strength may be more appropriate to administer the prescribed dose, and where the risk of overdosage has been assessed. It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40570\" outputclass=\"contraindications\" rev=\"1.19\" parent=\"/drugs/midazolam\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">CNS depression</ph>; <ph outputclass=\"contraindication\">compromised airway</ph>; <ph outputclass=\"contraindication\">severe respiratory depression</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40585\" outputclass=\"cautions\" rev=\"1.30\" parent=\"/drugs/midazolam\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Cardiac disease</ph>; <ph outputclass=\"caution\">children (particularly if cardiovascular impairment)</ph>; <ph outputclass=\"caution\">concentration of midazolam in children under 15&#8239;kg not to exceed 1&#8239;mg/mL</ph>; <ph outputclass=\"caution\">debilitated patients (reduce dose)</ph> (in children); <ph outputclass=\"caution\">hypothermia</ph>; <ph outputclass=\"caution\">hypovolaemia (risk of severe hypotension)</ph>; <ph outputclass=\"caution\">neonates</ph>; <ph outputclass=\"caution\">risk of airways obstruction and hypoventilation in children under 6 months (monitor respiratory rate and oxygen saturation)</ph>; <ph outputclass=\"caution\">vasoconstriction</ph>\n</p>\n</section>\n<section outputclass=\"importantAdvice\">\n<title>Cautions, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Recovery when used for sedation</p>\n<p>Midazolam has a fast onset of action, recovery is faster than for other benzodiazepines such as diazepam, but may be significantly longer in the elderly, in patients with a low cardiac output, or after repeated dosing.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40467\" outputclass=\"sideEffects\" rev=\"1.33\" parent=\"/drugs/midazolam\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Amnesia</ph>; <ph outputclass=\"sideEffect\">anaphylaxis</ph>; <ph outputclass=\"sideEffect\">ataxia</ph>; <ph outputclass=\"sideEffect\">blood disorders</ph>; <ph outputclass=\"sideEffect\">bronchospasm</ph>; <ph outputclass=\"sideEffect\">cardiac arrest</ph>; <ph outputclass=\"sideEffect\">changes in libido</ph> (in adults); <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">convulsions (more common in neonates)</ph>; <ph outputclass=\"sideEffect\">depression of consciousness</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">dry mouth</ph>; <ph outputclass=\"sideEffect\">dysarthria</ph>; <ph outputclass=\"sideEffect\">euphoria</ph>; <ph outputclass=\"sideEffect\">fatigue</ph> (in children); <ph outputclass=\"sideEffect\">gastro-intestinal disturbances</ph>; <ph outputclass=\"sideEffect\">hallucinations</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">heart rate changes</ph>; <ph outputclass=\"sideEffect\">hiccups</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">incontinence</ph>; <ph outputclass=\"sideEffect\">increased appetite</ph>; <ph outputclass=\"sideEffect\">injection-site reactions</ph>; <ph outputclass=\"sideEffect\">involuntary movements</ph>; <ph outputclass=\"sideEffect\">jaundice</ph>; <ph outputclass=\"sideEffect\">laryngospasm</ph>; <ph outputclass=\"sideEffect\">muscle weakness</ph>; <ph outputclass=\"sideEffect\">paradoxical aggression (especially in children and elderly)</ph>; <ph outputclass=\"sideEffect\">paradoxical excitement (especially in children and elderly)</ph>; <ph outputclass=\"sideEffect\">respiratory arrest (particularly with high doses or on rapid injection)</ph>; <ph outputclass=\"sideEffect\">respiratory depression (may be severe with sedative and peri-operative use&#8212;facilities for its treatment are essential)</ph>; <ph outputclass=\"sideEffect\">respiratory depression (particularly with high doses or on rapid injection)</ph>; <ph outputclass=\"sideEffect\">restlessness (with sedative and peri-operative use)</ph> (in children); <ph outputclass=\"sideEffect\">salivation changes</ph>; <ph outputclass=\"sideEffect\">severe disinhibition (with sedative and peri-operative use)</ph> (in children); <ph outputclass=\"sideEffect\">skin reactions</ph>; <ph outputclass=\"sideEffect\">thrombosis</ph>; <ph outputclass=\"sideEffect\">urinary retention</ph>; <ph outputclass=\"sideEffect\">vertigo</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With intranasal use</p>\n<p>\n<ph outputclass=\"sideEffect\">burning sensation</ph> (in children); <ph outputclass=\"sideEffect\">lacrimation</ph> (in children); <ph outputclass=\"sideEffect\">severe irritation of nasal mucosa</ph> (in children)</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p outputclass=\"title\">Sedation</p>\n<p>Midazolam is associated with profound sedation when high doses are given or when it is used with certain other drugs. Midazolam is not recommended for prolonged sedation in neonates; drug accumulation is likely to occur.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p outputclass=\"title\">Sedation</p>\n<p>Midazolam is associated with profound sedation when high doses are given or when it is used with certain other drugs.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsOverdosageInformation\">\n<title>Overdose</title>\n<sectiondiv>\n<p>There have been reports of overdosage when high strength midazolam has been used for conscious sedation. The use of high-strength midazolam (5&#8239;mg/mL in 2&#8239;mL and 10&#8239;mL ampoules, or 2&#8239;mg/mL in 5&#8239;mL ampoules) should be restricted to general anaesthesia, intensive care, palliative care, or other situations where the risk has been assessed. It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40492\" outputclass=\"pregnancy\" parent=\"/drugs/midazolam\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Women who have seizures in the second half of pregnancy should be assessed for eclampsia before any change is made to antiepileptic treatment. Status epilepticus should be treated according to the standard protocol.</p>\n<p>All pregnant women with epilepsy, whether taking medication or not, should be encouraged to notify the UK Epilepsy and Pregnancy Register (Tel: 0800 389 1248).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40590\" outputclass=\"breastFeeding\" parent=\"/drugs/midazolam\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Small amount present in milk&#8212;avoid breast-feeding for 24 hours after administration (although amount probably too small to be harmful after single doses).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40536\" outputclass=\"hepaticImpairment\" parent=\"/drugs/midazolam\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution particularly in sedative doses; can precipitate coma. For status epilepticus and febrile convulsions: use with caution in mild to moderate impairment; avoid in severe impairment.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40482\" outputclass=\"renalImpairment\" parent=\"/drugs/midazolam\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Use with caution in chronic renal failure.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40602\" outputclass=\"directionsForAdministration\" rev=\"1.26\" parent=\"/drugs/midazolam\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous injection</i> in status epilepticus and febrile convulsions, dilute with Glucose 5% or Sodium Chloride 0.9%; rapid intravenous injection (less than 2 minutes) may cause seizure-like myoclonus in preterm neonate.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in neonates</p>\n<p>\n<i>Neonatal intensive care</i>, dilute 15&#8239;mg/kg body-weight to a final volume of 50&#8239;mL with infusion fluid; an intravenous infusion rate of 0.1&#8239;mL/hour provides a dose of 30&#8239;micrograms/kg/hour.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>For administration <i>by mouth</i> for sedation and premedication, injection solution may be diluted with apple or black currant juice, chocolate sauce, or cola.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">rectal</ph> use in children</p>\n<p>For <i>rectal administration</i> of the injection solution for sedation and premedication, attach a plastic applicator onto the end of a syringe; if the volume to be given rectally is too small, dilute with Water for Injections.</p>\n</sectiondiv>\n<sectiondiv>\n<p>For <i>intravenous infusion</i> (<i>Hypnovel</i>\n<tm tmtype=\"reg\"/>), give continuously <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p>\n<p>For neonate and children under 15&#8239;kg dilute to a max. concentration of 1&#8239;mg/mL.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40489\" outputclass=\"patientAndCarerAdvice\" rev=\"1.22\" parent=\"/drugs/midazolam\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Midazolam for stopping seizures</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures\">www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use</p>\r\n<p>Patients or carers should be given advice on how to administer midazolam oromucosal solution.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p>Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risks of undertaking skilled tasks (e.g. driving) afterwards. For intravenous benzodiazepines the risk extends to <b>at least 24 hours</b> after administration. Responsible persons should be available to take patients home afterwards. The dangers of taking <b>alcohol</b> should be emphasised.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP3037-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/midazolam\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: tablet, solution for injection, oral suspension, solution for infusion, oral solution, oromucosal solution, infusion</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77306\" title=\"Oromucosal solution\" namespace=\"/drugs/midazolam/oromucosal-solution\">Oromucosal solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77320\" title=\"Solution for injection\" namespace=\"/drugs/midazolam/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77313\" title=\"Solution for infusion\" namespace=\"/drugs/midazolam/solution-for-infusion\">Solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP107735\" namespace=\"/guidance/prescribing-in-palliative-care\" title=\"Prescribing in palliative care\" count=\"4\" rel=\"backlink\">Prescribing in palliative care</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP97239\" namespace=\"/guidance/controlled-drugs-and-drug-dependence\" title=\"Controlled drugs and drug dependence\" count=\"3\" rel=\"backlink\">Controlled drugs and drug dependence</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98619\" namespace=\"/guidance/prescribing-in-dental-practice\" title=\"Prescribing in dental practice\" count=\"4\" rel=\"backlink\">Prescribing in dental practice</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78121\" namespace=\"/treatment-summaries/convulsive-including-febrile-seizures-lasting-longer-than-5-minutes-medical-emergency\" title=\"Convulsive (including febrile) seizures lasting longer than 5 minutes, medical emergency\" count=\"1\" rel=\"backlink\">Convulsive (including febrile) seizures lasting longer than 5 minutes, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78166\" namespace=\"/treatment-summaries/diabetes\" title=\"Diabetes\" count=\"1\" rel=\"backlink\">Diabetes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78230\" namespace=\"/treatment-summaries/epilepsy\" title=\"Epilepsy\" count=\"2\" rel=\"backlink\">Epilepsy</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78500\" namespace=\"/treatment-summaries/pre-medication-and-peri-operative-drugs\" title=\"Pre-medication and peri-operative drugs\" count=\"3\" rel=\"backlink\">Pre-medication and peri-operative drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78539\" namespace=\"/treatment-summaries/general-anaesthesia\" title=\"General anaesthesia\" count=\"1\" rel=\"backlink\">General anaesthesia</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78558\" namespace=\"/treatment-summaries/emergency-treatment-of-poisoning\" title=\"Emergency treatment of poisoning\" count=\"1\" rel=\"backlink\">Emergency treatment of poisoning</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_421\" namespace=\"/interactions/list-of-drug-interactions/anxiolytics-and-hypnotics/benzodiazepines/midazolam\" title=\"Midazolam\" count=\"1\" rel=\"link\">Midazolam</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34584\" namespace=\"/drug-classes/benzodiazepines\" title=\"BENZODIAZEPINES\" count=\"1\" rel=\"link\">BENZODIAZEPINES</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77306\" namespace=\"/drugs/midazolam/oromucosal-solution\" title=\"Oromucosal solution\" count=\"1\" rel=\"link\">Oromucosal solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77320\" namespace=\"/drugs/midazolam/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77313\" namespace=\"/drugs/midazolam/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP3037",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/midazolam",
    "basename": "midazolam",
    "title": "MIDAZOLAM",
    "interactants": [
        {
            "id": "bnf_int_421",
            "label": "Midazolam"
        }
    ],
    "vtmid": "26800000",
    "drugClassification": [
        "Hypnotics and sedatives (benzodiazepine)"
    ],
    "inheritsFromClass": [
        "BENZODIAZEPINES"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Status epilepticus",
                        "html": "Status epilepticus"
                    },
                    {
                        "textContent": "Febrile convulsions",
                        "html": "Febrile convulsions"
                    }
                ],
                "specificity": {
                    "routes": [
                        "buccal administration"
                    ],
                    "textContent": "By buccal administration",
                    "html": "By buccal administration"
                },
                "child": [
                    {
                        "textContent": "300 micrograms/kg (max. per dose 2.5 mg), then 300 micrograms/kg after 10 minutes (max. per dose 2.5 mg) if required.",
                        "html": "<p>300&#8239;micrograms/kg (max. per dose 2.5&#8239;mg), then 300&#8239;micrograms/kg after 10&#8239;minutes (max. per dose 2.5&#8239;mg) if required.</p>",
                        "ageGroup": "1&#8211;2 months"
                    },
                    {
                        "textContent": "2.5 mg, then 2.5 mg after 10 minutes if required.",
                        "html": "<p>2.5&#8239;mg, then 2.5&#8239;mg after 10&#8239;minutes if required.</p>",
                        "ageGroup": "3&#8211;11 months"
                    },
                    {
                        "textContent": "5 mg, then 5 mg after 10 minutes if required.",
                        "html": "<p>5&#8239;mg, then 5&#8239;mg after 10&#8239;minutes if required.</p>",
                        "ageGroup": "1&#8211;4 years"
                    },
                    {
                        "textContent": "7.5 mg, then 7.5 mg after 10 minutes if required.",
                        "html": "<p>7.5&#8239;mg, then 7.5&#8239;mg after 10&#8239;minutes if required.</p>",
                        "ageGroup": "5&#8211;9 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "10 mg, then 10 mg after 10 minutes if required.",
                        "html": "<p>10&#8239;mg, then 10&#8239;mg after 10&#8239;minutes if required.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Conscious sedation for procedures",
                        "html": "Conscious sedation for procedures"
                    }
                ],
                "specificity": {
                    "routes": [
                        "slow intravenous injection"
                    ],
                    "textContent": "By slow intravenous injection",
                    "html": "By slow intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 2&#8211;2.5 mg, to be administered 5&#8211;10 minutes before procedure at a rate of approximately 2 mg/minute, increased in steps of 1 mg if required, usual total dose is 3.5&#8211;5 mg; maximum 7.5 mg per course.",
                        "html": "<p>Initially 2&#8211;2.5&#8239;mg, to be administered 5&#8211;10 minutes before procedure at a rate of approximately 2&#8239;mg/minute, increased in steps of 1&#8239;mg if required, usual total dose is 3.5&#8211;5&#8239;mg; maximum 7.5&#8239;mg per course.</p>"
                    },
                    {
                        "textContent": "Initially 0.5&#8211;1 mg, to be administered 5&#8211;10 minutes before procedure at a rate of approximately 2 mg/minute, increased in steps of 0.5&#8211;1 mg if required; maximum 3.5 mg per course.",
                        "html": "<p>Initially 0.5&#8211;1&#8239;mg, to be administered 5&#8211;10 minutes before procedure at a rate of approximately 2&#8239;mg/minute, increased in steps of 0.5&#8211;1&#8239;mg if required; maximum 3.5&#8239;mg per course.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Sedative in combined anaesthesia",
                        "html": "Sedative in combined anaesthesia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "30&#8211;100 micrograms/kg, repeated if necessary, alternatively (by continuous intravenous infusion) 30&#8211;100 micrograms/kg/hour.",
                        "html": "<p>30&#8211;100&#8239;micrograms/kg, repeated if necessary, alternatively (by continuous intravenous infusion) 30&#8211;100&#8239;micrograms/kg/hour.</p>"
                    },
                    {
                        "textContent": "Lower doses needed.",
                        "html": "<p>Lower doses needed.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Premedication",
                        "html": "Premedication"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "70&#8211;100 micrograms/kg, to be administered 20&#8211;60 minutes before induction, for debilitated patients, use elderly dose.",
                        "html": "<p>70&#8211;100&#8239;micrograms/kg, to be administered 20&#8211;60 minutes before induction, for debilitated patients, use elderly dose.</p>"
                    },
                    {
                        "textContent": "25&#8211;50 micrograms/kg, to be administered 20&#8211;60 minutes before induction.",
                        "html": "<p>25&#8211;50&#8239;micrograms/kg, to be administered 20&#8211;60 minutes before induction.</p>",
                        "ageGroup": "elderly"
                    },
                    {
                        "textContent": "1&#8211;2 mg, repeated if necessary, to be administered 5&#8211;30 minutes before procedure, for debilitated patients, use elderly dose.",
                        "html": "<p>1&#8211;2&#8239;mg, repeated if necessary, to be administered 5&#8211;30 minutes before procedure, for debilitated patients, use elderly dose.</p>"
                    },
                    {
                        "textContent": "0.5 mg, repeated if necessary, initial dose to be administered 5&#8211;30 minutes before procedure, repeat dose slowly as required.",
                        "html": "<p>0.5&#8239;mg, repeated if necessary, initial dose to be administered 5&#8211;30 minutes before procedure, repeat dose slowly as required.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Induction of anaesthesia (but rarely used)",
                        "html": "Induction of anaesthesia (but rarely used)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "slow intravenous injection"
                    ],
                    "textContent": "By slow intravenous injection",
                    "html": "By slow intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "150&#8211;200 micrograms/kg daily in divided doses (max. per dose 5 mg), dose to be given at intervals of 2 minutes, maximum total dose 600 micrograms/kg, for debilitated patients, use elderly dose.",
                        "html": "<p>150&#8211;200&#8239;micrograms/kg daily in divided doses (max. per dose 5&#8239;mg), dose to be given at intervals of 2 minutes, maximum total dose 600&#8239;micrograms/kg, for debilitated patients, use elderly dose.</p>"
                    },
                    {
                        "textContent": "50&#8211;150 micrograms/kg daily in divided doses (max. per dose 5 mg), dose to be given at intervals of 2 minutes, maximum total dose 600 micrograms/kg.",
                        "html": "<p>50&#8211;150&#8239;micrograms/kg daily in divided doses (max. per dose 5&#8239;mg), dose to be given at intervals of 2 minutes, maximum total dose 600&#8239;micrograms/kg.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Sedation of patient receiving intensive care",
                        "html": "Sedation of patient receiving intensive care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially slow intravenous injection"
                    ],
                    "textContent": "Initially by slow intravenous injection",
                    "html": "Initially by slow intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 30&#8211;300 micrograms/kg, dose to be given in steps of 1&#8211;2.5 mg every 2 minutes, then (by slow intravenous injection or by continuous intravenous infusion) 30&#8211;200 micrograms/kg/hour, reduce dose (or reduce or omit initial dose) in hypovolaemia, vasoconstriction, or hypothermia, lower doses may be adequate if opioid analgesic also used.",
                        "html": "<p>Initially 30&#8211;300&#8239;micrograms/kg, dose to be given in steps of 1&#8211;2.5&#8239;mg every 2 minutes, then (by slow intravenous injection or by continuous intravenous infusion) 30&#8211;200&#8239;micrograms/kg/hour, reduce dose (or reduce or omit initial dose) in hypovolaemia, vasoconstriction, or hypothermia, lower doses may be adequate if opioid analgesic also used.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Confusion and restlessness in palliative care",
                        "html": "Confusion and restlessness in palliative care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "subcutaneous infusion"
                    ],
                    "textContent": "By subcutaneous infusion",
                    "html": "By subcutaneous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 10&#8211;20 mg/24 hours, adjusted according to response; usual dose 20&#8211;60 mg/24 hours.",
                        "html": "<p>Initially 10&#8211;20&#8239;mg/24 hours, adjusted according to response; usual dose 20&#8211;60&#8239;mg/24 hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Convulsions in palliative care",
                        "html": "Convulsions in palliative care"
                    }
                ],
                "specificity": {
                    "routes": [
                        "continuous subcutaneous infusion"
                    ],
                    "textContent": "By continuous subcutaneous infusion",
                    "html": "By continuous subcutaneous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 20&#8211;40 mg/24 hours.",
                        "html": "<p>Initially 20&#8211;40&#8239;mg/24 hours.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Oromucosal solution not licensed for use in children under 3 months.\n\nOromucosal solution not licensed for use in adults over 18 years.\n\nUnlicensed oromucosal formulations are also available and may have different doses&#8212;refer to product literature.\n\nInjection not licensed for use in status epilepticus or febrile convulsions.",
                "html": "<p>Oromucosal solution not licensed for use in children under 3 months.</p><p>Oromucosal solution not licensed for use in adults over 18 years.</p><p>Unlicensed oromucosal formulations are also available and may have different doses&#8212;refer to product literature.</p><p>Injection not licensed for use in status epilepticus or febrile convulsions.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Not licensed for use in children under 6 months for premedication and conscious sedation.\n\nNot licensed for use by mouth.\n\nNot licensed for use by buccal administration for conscious sedation.",
                "html": "<p>Not licensed for use in children under 6 months for premedication and conscious sedation.</p><p>Not licensed for use by mouth.</p><p>Not licensed for use by buccal administration for conscious sedation.</p>"
            }
        ]
    },
    "importantSafetyInformation": {
        "importantSafetyInformation": [
            {
                "type": "importantSafetyInformation",
                "title": "Anaesthesia",
                "textContent": "Benzodiazepines should only be administered for anaesthesia by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management.",
                "html": "<p>Benzodiazepines should only be administered for anaesthesia by, or under the direct supervision of, personnel experienced in their use, with adequate training in anaesthesia and airway management.</p>"
            },
            {
                "type": "importantSafetyInformation",
                "title": "Prescribing of midazolam in pallative care",
                "textContent": "The use of high-strength midazolam (5 mg/mL in 2 mL and 10 mL ampoules, or 2 mg/mL in 5 mL ampoules) should be considered in palliative care and other situations where a higher strength may be more appropriate to administer the prescribed dose, and where the risk of overdosage has been assessed. It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.",
                "html": "<p>The use of high-strength midazolam (5&#8239;mg/mL in 2&#8239;mL and 10&#8239;mL ampoules, or 2&#8239;mg/mL in 5&#8239;mL ampoules) should be considered in palliative care and other situations where a higher strength may be more appropriate to administer the prescribed dose, and where the risk of overdosage has been assessed. It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.</p>"
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "CNS depression",
                "html": "CNS depression"
            },
            {
                "type": "contraindications",
                "textContent": "compromised airway",
                "html": "compromised airway"
            },
            {
                "type": "contraindications",
                "textContent": "severe respiratory depression",
                "html": "severe respiratory depression"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Cardiac disease",
                "html": "Cardiac disease"
            },
            {
                "type": "cautions",
                "textContent": "children (particularly if cardiovascular impairment)",
                "html": "children (particularly if cardiovascular impairment)"
            },
            {
                "type": "cautions",
                "textContent": "concentration of midazolam in children under 15 kg not to exceed 1 mg/mL",
                "html": "concentration of midazolam in children under 15&#8239;kg not to exceed 1&#8239;mg/mL"
            },
            {
                "type": "cautions",
                "textContent": "debilitated patients (reduce dose) in children",
                "html": "debilitated patients (reduce dose) in children",
                "specificity": {
                    "patientType": "children"
                }
            },
            {
                "type": "cautions",
                "textContent": "hypothermia",
                "html": "hypothermia"
            },
            {
                "type": "cautions",
                "textContent": "hypovolaemia (risk of severe hypotension)",
                "html": "hypovolaemia (risk of severe hypotension)"
            },
            {
                "type": "cautions",
                "textContent": "neonates",
                "html": "neonates"
            },
            {
                "type": "cautions",
                "textContent": "risk of airways obstruction and hypoventilation in children under 6 months (monitor respiratory rate and oxygen saturation)",
                "html": "risk of airways obstruction and hypoventilation in children under 6 months (monitor respiratory rate and oxygen saturation)"
            },
            {
                "type": "cautions",
                "textContent": "vasoconstriction",
                "html": "vasoconstriction"
            }
        ],
        "importantAdvice": [
            {
                "type": "importantAdvice",
                "title": "Recovery when used for sedation",
                "textContent": "Midazolam has a fast onset of action, recovery is faster than for other benzodiazepines such as diazepam, but may be significantly longer in the elderly, in patients with a low cardiac output, or after repeated dosing.",
                "html": "<p>Midazolam has a fast onset of action, recovery is faster than for other benzodiazepines such as diazepam, but may be significantly longer in the elderly, in patients with a low cardiac output, or after repeated dosing.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Amnesia",
                        "html": "Amnesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anaphylaxis",
                        "html": "anaphylaxis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "ataxia",
                        "html": "ataxia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "blood disorders",
                        "html": "blood disorders",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "bronchospasm",
                        "html": "bronchospasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "cardiac arrest",
                        "html": "cardiac arrest",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in libido in adults",
                        "html": "changes in libido in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known",
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "convulsions (more common in neonates)",
                        "html": "convulsions (more common in neonates)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression of consciousness",
                        "html": "depression of consciousness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dry mouth",
                        "html": "dry mouth",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dysarthria",
                        "html": "dysarthria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "euphoria",
                        "html": "euphoria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "fatigue in children",
                        "html": "fatigue in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known",
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "gastro-intestinal disturbances",
                        "html": "gastro-intestinal disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hallucinations",
                        "html": "hallucinations",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "heart rate changes",
                        "html": "heart rate changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hiccups",
                        "html": "hiccups",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "incontinence",
                        "html": "incontinence",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "increased appetite",
                        "html": "increased appetite",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "injection-site reactions",
                        "html": "injection-site reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "involuntary movements",
                        "html": "involuntary movements",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "jaundice",
                        "html": "jaundice",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "laryngospasm",
                        "html": "laryngospasm",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle weakness",
                        "html": "muscle weakness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paradoxical aggression (especially in children and elderly)",
                        "html": "paradoxical aggression (especially in children and elderly)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paradoxical excitement (especially in children and elderly)",
                        "html": "paradoxical excitement (especially in children and elderly)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "respiratory arrest (particularly with high doses or on rapid injection)",
                        "html": "respiratory arrest (particularly with high doses or on rapid injection)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "respiratory depression (may be severe with sedative and peri-operative use&#8212;facilities for its treatment are essential)",
                        "html": "respiratory depression (may be severe with sedative and peri-operative use&#8212;facilities for its treatment are essential)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "respiratory depression (particularly with high doses or on rapid injection)",
                        "html": "respiratory depression (particularly with high doses or on rapid injection)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "restlessness (with sedative and peri-operative use) in children",
                        "html": "restlessness (with sedative and peri-operative use) in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known",
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "salivation changes",
                        "html": "salivation changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "severe disinhibition (with sedative and peri-operative use) in children",
                        "html": "severe disinhibition (with sedative and peri-operative use) in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known",
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "skin reactions",
                        "html": "skin reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombosis",
                        "html": "thrombosis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urinary retention",
                        "html": "urinary retention",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vertigo",
                        "html": "vertigo",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "burning sensation in children",
                        "html": "burning sensation in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intranasal use",
                            "html": "With intranasal use",
                            "routes": [
                                "intranasal"
                            ],
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "lacrimation in children",
                        "html": "lacrimation in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intranasal use",
                            "html": "With intranasal use",
                            "routes": [
                                "intranasal"
                            ],
                            "patientType": "children"
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "severe irritation of nasal mucosa in children",
                        "html": "severe irritation of nasal mucosa in children",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With intranasal use",
                            "html": "With intranasal use",
                            "routes": [
                                "intranasal"
                            ],
                            "patientType": "children"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Sedation",
                "textContent": "Midazolam is associated with profound sedation when high doses are given or when it is used with certain other drugs. Midazolam is not recommended for prolonged sedation in neonates; drug accumulation is likely to occur.",
                "html": "<p>Midazolam is associated with profound sedation when high doses are given or when it is used with certain other drugs. Midazolam is not recommended for prolonged sedation in neonates; drug accumulation is likely to occur.</p>"
            },
            {
                "type": "advice",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "title": "Sedation",
                "textContent": "Midazolam is associated with profound sedation when high doses are given or when it is used with certain other drugs.",
                "html": "<p>Midazolam is associated with profound sedation when high doses are given or when it is used with certain other drugs.</p>"
            }
        ],
        "overdosageInformation": [
            {
                "type": "overdosageInformation",
                "textContent": "There have been reports of overdosage when high strength midazolam has been used for conscious sedation. The use of high-strength midazolam (5 mg/mL in 2 mL and 10 mL ampoules, or 2 mg/mL in 5 mL ampoules) should be restricted to general anaesthesia, intensive care, palliative care, or other situations where the risk has been assessed. It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.",
                "html": "<p>There have been reports of overdosage when high strength midazolam has been used for conscious sedation. The use of high-strength midazolam (5&#8239;mg/mL in 2&#8239;mL and 10&#8239;mL ampoules, or 2&#8239;mg/mL in 5&#8239;mL ampoules) should be restricted to general anaesthesia, intensive care, palliative care, or other situations where the risk has been assessed. It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Women who have seizures in the second half of pregnancy should be assessed for eclampsia before any change is made to antiepileptic treatment. Status epilepticus should be treated according to the standard protocol.\n\nAll pregnant women with epilepsy, whether taking medication or not, should be encouraged to notify the UK Epilepsy and Pregnancy Register (Tel: 0800 389 1248).",
                "html": "<p>Women who have seizures in the second half of pregnancy should be assessed for eclampsia before any change is made to antiepileptic treatment. Status epilepticus should be treated according to the standard protocol.</p><p>All pregnant women with epilepsy, whether taking medication or not, should be encouraged to notify the UK Epilepsy and Pregnancy Register (Tel: 0800 389 1248).</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Small amount present in milk&#8212;avoid breast-feeding for 24 hours after administration (although amount probably too small to be harmful after single doses).",
                "html": "<p>Small amount present in milk&#8212;avoid breast-feeding for 24 hours after administration (although amount probably too small to be harmful after single doses).</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution particularly in sedative doses; can precipitate coma. For status epilepticus and febrile convulsions: use with caution in mild to moderate impairment; avoid in severe impairment.",
                "html": "<p>Use with caution particularly in sedative doses; can precipitate coma. For status epilepticus and febrile convulsions: use with caution in mild to moderate impairment; avoid in severe impairment.</p>"
            }
        ]
    },
    "renalImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Use with caution in chronic renal failure.",
                "html": "<p>Use with caution in chronic renal failure.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous injection in status epilepticus and febrile convulsions, dilute with Glucose 5% or Sodium Chloride 0.9%; rapid intravenous injection (less than 2 minutes) may cause seizure-like myoclonus in preterm neonate.",
                "html": "<p>For <i>intravenous injection</i> in status epilepticus and febrile convulsions, dilute with Glucose 5% or Sodium Chloride 0.9%; rapid intravenous injection (less than 2 minutes) may cause seizure-like myoclonus in preterm neonate.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in neonates",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in neonates",
                    "patientType": "neonates",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Neonatal intensive care, dilute 15 mg/kg body-weight to a final volume of 50 mL with infusion fluid; an intravenous infusion rate of 0.1 mL/hour provides a dose of 30 micrograms/kg/hour.",
                "html": "<p>\n<i>Neonatal intensive care</i>, dilute 15&#8239;mg/kg body-weight to a final volume of 50&#8239;mL with infusion fluid; an intravenous infusion rate of 0.1&#8239;mL/hour provides a dose of 30&#8239;micrograms/kg/hour.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "For administration by mouth for sedation and premedication, injection solution may be diluted with apple or black currant juice, chocolate sauce, or cola.",
                "html": "<p>For administration <i>by mouth</i> for sedation and premedication, injection solution may be diluted with apple or black currant juice, chocolate sauce, or cola.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With rectal use in children",
                    "html": "With <ph outputclass=\"route\">rectal</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "rectal"
                    ]
                },
                "textContent": "For rectal administration of the injection solution for sedation and premedication, attach a plastic applicator onto the end of a syringe; if the volume to be given rectally is too small, dilute with Water for Injections.",
                "html": "<p>For <i>rectal administration</i> of the injection solution for sedation and premedication, attach a plastic applicator onto the end of a syringe; if the volume to be given rectally is too small, dilute with Water for Injections.</p>"
            },
            {
                "type": "directionsForAdministration",
                "textContent": "For intravenous infusion (Hypnovel ), give continuously in Glucose 5% or Sodium chloride 0.9%.\n\nFor neonate and children under 15 kg dilute to a max. concentration of 1 mg/mL.",
                "html": "<p>For <i>intravenous infusion</i> (<i>Hypnovel</i>\n<tm tmtype=\"reg\"/>), give continuously <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p><p>For neonate and children under 15&#8239;kg dilute to a max. concentration of 1&#8239;mg/mL.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures",
                        "label": "www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Midazolam for stopping seizures",
                "textContent": "www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures\">www.medicinesforchildren.org.uk/midazolam-for-stopping-seizures</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With <ph outputclass=\"route\">oral</ph> use",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Patients or carers should be given advice on how to administer midazolam oromucosal solution.",
                "html": "<p>Patients or carers should be given advice on how to administer midazolam oromucosal solution.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risks of undertaking skilled tasks (e.g. driving) afterwards. For intravenous benzodiazepines the risk extends to at least 24 hours after administration. Responsible persons should be available to take patients home afterwards. The dangers of taking alcohol should be emphasised.",
                "html": "<p>Patients given sedatives and analgesics during minor outpatient procedures should be very carefully warned about the risks of undertaking skilled tasks (e.g. driving) afterwards. For intravenous benzodiazepines the risk extends to <b>at least 24 hours</b> after administration. Responsible persons should be available to take patients home afterwards. The dangers of taking <b>alcohol</b> should be emphasised.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "tablet",
                "solution for injection",
                "oral suspension",
                "solution for infusion",
                "oral solution",
                "oromucosal solution",
                "infusion"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77306",
                "label": "Oromucosal solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77320",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77313",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP107735",
                "label": "Prescribing in palliative care",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP97239",
                "label": "Controlled drugs and drug dependence",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP98619",
                "label": "Prescribing in dental practice",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78121",
                "label": "Convulsive (including febrile) seizures lasting longer than 5 minutes, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78166",
                "label": "Diabetes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78230",
                "label": "Epilepsy",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78500",
                "label": "Pre-medication and peri-operative drugs",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78539",
                "label": "General anaesthesia",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78558",
                "label": "Emergency treatment of poisoning",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_421",
                "label": "Midazolam",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34584",
                "label": "BENZODIAZEPINES",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77306",
                "label": "Oromucosal solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77320",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77313",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}